Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001140361-25-044419
Filing Date
2025-12-04
Accepted
2025-12-04 21:56:02
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 6694
2 EXHIBIT 99.A ef20060702_ex99-a.htm EX-99.A 6954
  Complete submission text file 0001140361-25-044419.txt   15320
Mailing Address 620 LESHER PLACE LANSING MI 48912
Business Address 620 LESHER PLACE LANSING MI 48912 5173729200
NEOGEN CORP (Subject) CIK: 0000711377 (see all company filings)

EIN.: 382367843 | State of Incorp.: MI | Fiscal Year End: 0531
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-40503 | Film No.: 251551061
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)

Mailing Address PO BOX 1800 AMSTERDAM P7 1000 BV
Business Address PO BOX 1800 AMSTERDAM P7 1000 BV 01131205639111
ING GROEP NV (Filed by) CIK: 0001039765 (see all company filings)

EIN.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A
SIC: 6029 Commercial Banks, NEC
(CF Office: 02 Finance)